High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome.
about
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?Targeted Nanocarriers for Imaging and Therapy of Vascular Inflammation.Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect.A carbohydrate-grafted nanovesicle with activatable optical and acoustic contrasts for dual modality high performance tumor imagingIn vivo targeting of B-cell lymphoma with glycan ligands of CD22.Liposomes modified by carbohydrate ligands can target B cells for the treatment of B-cell lymphomas.Siglecs as targets for therapy in immune-cell-mediated disease.Targeted drug-delivery approaches by nanoparticulate carriers in the therapy of inflammatory diseases.Toxicity of nanomaterials to the eye.Chemical tools for studying the biological function of glycolipids.Nanoparticles in the ocular drug delivery.Targeted endothelial nanomedicine for common acute pathological conditions.Moving forward in uveitis therapy: preclinical to phase II clinical trial drug development.Hyperlipidemia-induced cholesterol crystal production by endothelial cells promotes atherogenesis.Light and electron microscopic detection of inflammation-targeting liposomes encapsulating high-density colloidal gold in arthritic mice.
P2860
Q24599399-89E2D7C2-02CB-407B-8EF6-CD4DE93F7529Q30466992-F79DF21A-8501-473D-9B43-5D0BCEC59152Q33689872-A2F20993-7931-4AEA-BAAE-3AF46AD4FCF2Q33869355-539D2E2C-6D1E-431F-91CC-01A66F690BC5Q33931886-70803E32-8002-4ED2-AF83-65F366A1EC42Q34470480-13E2934F-68B8-44CF-B7EB-A7A08055F719Q37440061-28AA929E-B41C-404E-83A3-9517AB4AE661Q37638947-793C8E32-6E3C-4963-BAA4-8EF3FB6004E5Q37676123-229C2760-A953-42EA-8DA2-F029BF495FB5Q38115508-756383A3-8B73-4D07-B569-B2BA9EBAD29AQ38119238-EA08D447-FD04-4AC0-9213-FA9F478ACABCQ38598987-DBE254D4-A278-4C35-93D9-5CF88AE93D43Q38660708-4479EC3B-FD86-4532-B7D4-23E6CBC210EFQ42639851-BF4DE28F-2D27-4FBC-A5E0-AECA71C01614Q43664324-E61B682F-8804-48C9-B6FE-4948FBDF56BD
P2860
High-efficacy site-directed drug delivery system using sialyl-Lewis X conjugated liposome.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
High-efficacy site-directed dr ...... l-Lewis X conjugated liposome.
@ast
High-efficacy site-directed dr ...... l-Lewis X conjugated liposome.
@en
High-efficacy site-directed dr ...... l-Lewis X conjugated liposome.
@nl
type
label
High-efficacy site-directed dr ...... l-Lewis X conjugated liposome.
@ast
High-efficacy site-directed dr ...... l-Lewis X conjugated liposome.
@en
High-efficacy site-directed dr ...... l-Lewis X conjugated liposome.
@nl
prefLabel
High-efficacy site-directed dr ...... l-Lewis X conjugated liposome.
@ast
High-efficacy site-directed dr ...... l-Lewis X conjugated liposome.
@en
High-efficacy site-directed dr ...... l-Lewis X conjugated liposome.
@nl
P2093
P1476
High-efficacy site-directed dr ...... l-Lewis X conjugated liposome.
@en
P2093
Hisashi Mashimo
Noboru Yamazaki
Nobuo Kurokawa
Nobuyuki Ohguro
Noriyasu Hashida
Yasuo Tano
Yukio Arakawa
P304
P356
10.1016/J.EXER.2007.10.004
P577
2007-10-22T00:00:00Z